Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

The distribution of secretory leukocyte protease inhibitor (SLPI) at entry portals indicates its involvement in defending the host from pathogens, consistent with the ability of SLPI to inhibit human immunodeficiency virus (HIV)-1 infection by an unknown mechanism. We now demonstrate that SLPI binds...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ge, Greenwell-Wild, Teresa, Lei, Kejian, Jin, Wenwen, Swisher, Jennifer, Hardegen, Neil, Wild, Carl T., Wahl, Sharon M.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211913/
https://www.ncbi.nlm.nih.gov/pubmed/15545357
http://dx.doi.org/10.1084/jem.20041115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211913/
https://www.ncbi.nlm.nih.gov/pubmed/15545357
http://dx.doi.org/10.1084/jem.20041115

Ejemplares similares